Researchers
Hom, Christy
University of California, Irvine
INCLUDE Grants
Metabolic Health, Lifestyle, and Risk of Co-Occurring Health Conditions in Down Syndrome (MET-DS)
Grant Number
U01HD116477
NIH Institute
NICHD
Mechanism
U01
The Metabolic Health, Lifestyle, and Risk of Co-Occurring Health Conditions in Down Syndrome (MET-DS) study is a five-year, longitudinal deep-phenotyping study of factors driving the risk and severity of co-occurring conditions in children, adolescents, and young adults with Down syndrome, funded by the NIH INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE). The study involves a rigorous protocol for understanding the complex interplay between trisomy 21, metabolic dysregulation, obesity, lifestyle, and the development of co-occurring conditions across childhood, adolescence, and into young adulthood in people with Down syndrome. This effort will enroll 200 participants (ages 6-24 years of age) with Down syndrome from four clinical performance sites, and track conditions and variables across 3 data collection cycles.
Publications
-
Alzheimer's & dementia : the journal of the Alzheimer's Association
Alzheimer’s Disease Research Center Down Syndrome Cores: Experience from two sites. -
Alzheimer's & dementia : the journal of the Alzheimer's Association
Joint spatial associations of amyloid beta and tau pathology in Down syndrome and preclinical Alzheimer’s disease: Cross-sectional associations with early cognitive impairments. -
Alzheimer's & dementia : the journal of the Alzheimer's Association
The Alzheimer’s Biomarker Consortium-Down Syndrome (ABC-DS): A 10-year report. -
EBioMedicine
The effects of mosaicism on biological and clinical markers of Alzheimer’s disease in adults with Down syndrome. -
Journal of Alzheimer's disease : JAD
Insomnia Symptoms Are Associated with Measures of Functional Deterioration and Dementia Status in Adults with Down Syndrome at High Risk for Alzheimer’s Disease. -
Disability and health journal
Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome. -
Alzheimer's & dementia (Amsterdam, Netherlands)
Joint-label fusion brain atlases for dementia research in Down syndrome.